Cargando…
The future of heart failure with preserved ejection fraction: Deep phenotyping for targeted therapeutics
Heart failure (HF) with preserved ejection fraction (HFpEF) is a multi-organ, systemic syndrome that involves multiple cardiac and extracardiac pathophysiologic abnormalities. Because HFpEF is a heterogeneous syndrome and resistant to a “one-size-fits-all” approach it has proven to be very difficult...
Autores principales: | Heinzel, Frank R., Shah, Sanjiv J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Medizin
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244058/ https://www.ncbi.nlm.nih.gov/pubmed/35767073 http://dx.doi.org/10.1007/s00059-022-05124-8 |
Ejemplares similares
-
Comorbidities in heart failure with preserved ejection fraction
por: Deichl, Andrea, et al.
Publicado: (2022) -
Management strategies in heart failure with preserved ejection fraction
por: Wintrich, Jan, et al.
Publicado: (2022) -
Vagal stimulation in heart failure
por: Dusi, Veronica, et al.
Publicado: (2021) -
Drug treatment of heart failure in the elderly
por: Berliner, D., et al.
Publicado: (2018) -
Key inflammatory mechanisms underlying heart failure
por: Riehle, C., et al.
Publicado: (2019)